News Archives - Page 2 of 4

Stem cells Sunday brunch of good news, fun links, & cool papers

May 21, 2017 / Professor Paul Knoepfler, Ph.D. / 1 Comment

Enjoy! A Sunday brunch for the brain of science news, helpful links, and notable new papers including on stem cells. News and links CBER Director Focuses on Flexibility to Advance Regenerative Medicines Lab-Grown Blood Stem Cells Produced at Last Transplanted stem cells become eggs in sterile mice Maryland fund awards $8.5 million for stem cell research Positively good news from Asterias […]

Stem cells Sunday brunch of good news, fun links, & cool papers Read More »

Stem cell headlines: half a genome, Australian snake oil, CRISPR patent battle

March 20, 2016 / Professor Paul Knoepfler, Ph.D. / 6 Comments

There’s a lot going on in the world of stem cells making for many striking headlines lately. Here are some stem cell headlines that caught my attention. Haploid Stem Cells Created. Could these cells be used to make germ cells? Charlatans and snake-oil salesmen ‘hijacking stem cell therapies’ in Australia In the CRISPR patent fight, the Broad Institute gains edge. The CRISPR-Cas9 patent

Stem cell headlines: half a genome, Australian snake oil, CRISPR patent battle Read More »

Stem Cell News Briefs: NYSCF, Sleep & Transplants, NFL legends, & More

November 29, 2015 / Professor Paul Knoepfler, Ph.D.

What’s been up the past week in terms of news in the stem cell world? The Wall Street Journal reports that the New York Stem Cell Foundation (NYSCF) has signed a 20-year lease on a much larger space, in fact twice the current size, in Manhattan. That would seem to be a great sign of

Stem Cell News Briefs: NYSCF, Sleep & Transplants, NFL legends, & More Read More »

Stem Cell News Briefs: Anversa, Japan Regs, Ocata Suit, More

November 22, 2015 / Professor Paul Knoepfler, Ph.D. / 3 Comments

It’s been a busy few weeks for the stem cell field. Below are some news briefs on developments. RetractionWatch reports that Piero Anversa is leaving Harvard/Brigham and Women’s Hospital after an investigation and dismissed lawsuit he filed against the institution. All still quiet on the STAP cell front at the same institutions. There’s some more

Stem Cell News Briefs: Anversa, Japan Regs, Ocata Suit, More Read More »

Statins dilemma: heart & cancer benefits, but diabetes risk

May 12, 2015 / Professor Paul Knoepfler, Ph.D. / 7 Comments

Statins have been hailed as some of the best drugs ever. Given the massive, deadly prevalence of cardiovascular disease, some have even semi-jokingly talked about putting these drugs in the water supply for public health. The growing evidence (e.g. this story) that statins might significantly aid in prevention, delayed progression, or even post-treatment delay of

Statins dilemma: heart & cancer benefits, but diabetes risk Read More »

10 tips on mandatory new NIH biosketch & example

March 16, 2015 / Professor Paul Knoepfler, Ph.D. / 12 Comments

Got your new mandatory NIH biosketch all done? I didn’t think so. Want some help? Read on. NIH has done research and come up with a new biosketch for all of us to use with our proposals. It’s not optional. Originally it was going to be required for January 2015 proposals, but now it must

10 tips on mandatory new NIH biosketch & example Read More »

The Odd Couple of Cloning Research: Mitalipov & Woo Suk Hwang Unite

February 11, 2015 / Professor Paul Knoepfler, Ph.D. / 13 Comments

Remember that old TV show the Odd Couple with very proper Felix Unger and his polar opposite Oscar Madison who has all kinds of baggage? They’ve cloned it into a remake to be on TV soon here in the US in 2015. It seems only fitting then that actual human cloning research has a new

The Odd Couple of Cloning Research: Mitalipov & Woo Suk Hwang Unite Read More »

Stem Cell Tourism and Patient Education

September 23, 2014 / Professor Paul Knoepfler, Ph.D. / 13 Comments

What is the role of public education and stem cell tourism? What type of education is available to patients, caregivers and the public? Can public education actually change people’s minds such that they won’t undergo an unproven stem cell-based intervention (SCBI)? These are the questions I will discuss here. But first, let’s just give a

Stem Cell Tourism and Patient Education Read More »

StemCells, Inc. Faces Lawsuit With Serious Allegations

July 16, 2014 / Professor Paul Knoepfler, Ph.D. / 12 Comments

StemCells, Inc. is one of those stem cell-related biotech companies that we in the field hope will become a big success and help many patients in the future via stem cell technology. There are a lot of obstacles facing such companies. Some are privately held, while others such as StemCells, Inc. are publicly traded (stock

StemCells, Inc. Faces Lawsuit With Serious Allegations Read More »

What are important, recent stem cell good news stories?

May 16, 2014 / Professor Paul Knoepfler, Ph.D. / 5 Comments

Sometimes there is so much craziness and outright bad stuff going on out there around the world related to stem cells that we can lose sight of all the good news and encouraging developments as well. I think the new paper (Chen, et al.) from a team led by Drs. Lane and Loring is good news.

What are important, recent stem cell good news stories? Read More »

News

Subscribe to Our Newsletter